Richard M Turner

6PUBLICATIONS
44CO-AUTHORS
Cancer geneticsPharmacogenomicsPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 31, 2024
Large-Scale Pharmacogenomics Analysis of Patients With Cancer Within the 100,000 Genomes Project Combining Whole-Genome Sequencing and Medical Records to Inform Clinical Practice.

Ivone U S Leong, Claudia P Cabrera, Valentina Cipriani

|Mar 29, 2022
Pharmacogenomics: Relevance and opportunities for clinical pharmacology.

Richard M Turner, Emma F Magavern, Munir Pirmohamed

|Mar 24, 2022
Cardiovascular drugs and COVID-19 clinical outcomes: a systematic review and meta-analysis of randomized controlled trials.

Innocent G Asiimwe, Sudeep P Pushpakom, Richard M Turner

|Feb 27, 2021
The role of pharmacogenomics in contemporary cardiovascular therapy: a position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy.

Emma Forton Magavern, Juan Carlos Kaski, Richard M Turner

|Jun 06, 2020
Pharmacogenomics of anticancer drugs: Personalising the choice and dose to manage drug response.

Daniel F Carr, Richard M Turner, Munir Pirmohamed

|Oct 28, 2019
Investigating the clinical factors and comedications associated with circulating levels of atorvastatin and its major metabolites in secondary prevention.

Richard M Turner, Vanessa Fontana, Richard FitzGerald

Pageof 1

Frequent Collaborators

4 joint publications

Munir Pirmohamed

1 joint publications

Daniel F Carr

1 joint publications

Emma Forton Magavern

1 joint publications

Juan Carlos Kaski